Establishment Labs Holdings Inc (ESTA) Receives Consensus Rating of “Strong Buy” from Brokerages

Share on StockTwits

Shares of Establishment Labs Holdings Inc (NASDAQ:ESTA) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the three analysts that provide coverage for the stock, Zacks Investment Research reports. Three equities research analysts have rated the stock with a strong buy recommendation.

Analysts have set a one year consensus target price of $35.00 for the company and are anticipating that the company will post ($0.48) EPS for the current quarter, according to Zacks. Zacks has also assigned Establishment Labs an industry rank of 69 out of 255 based on the ratings given to related companies.

A number of research analysts have commented on the company. Zacks Investment Research lowered Establishment Labs from a “hold” rating to a “sell” rating in a research report on Monday, October 15th. BTIG Research initiated coverage on Establishment Labs in a report on Monday, August 13th. They set a “buy” rating and a $35.00 target price on the stock. Cowen initiated coverage on Establishment Labs in a report on Monday, August 13th. They set an “outperform” rating and a $35.00 target price on the stock. Finally, Jefferies Financial Group initiated coverage on Establishment Labs in a report on Monday, August 13th. They set a “buy” rating and a $35.00 target price on the stock.

ESTA opened at $23.85 on Wednesday. The company has a debt-to-equity ratio of 8.73, a current ratio of 2.42 and a quick ratio of 1.71. Establishment Labs has a one year low of $22.03 and a one year high of $30.70.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings results on Tuesday, August 14th. The company reported ($0.35) EPS for the quarter, beating analysts’ consensus estimates of ($0.50) by $0.15. The business had revenue of $13.71 million for the quarter, compared to the consensus estimate of $12.10 million. Analysts expect that Establishment Labs will post -1.66 EPS for the current fiscal year.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name.

Featured Story: How accurate is the Rule of 72?

Get a free copy of the Zacks research report on Establishment Labs (ESTA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Internap Corp  Receives $18.00 Consensus Target Price from Analysts
Internap Corp Receives $18.00 Consensus Target Price from Analysts
Moss Coin Reaches Market Capitalization of $10.06 Million
Moss Coin Reaches Market Capitalization of $10.06 Million
Arbutus Biopharma Corp  Expected to Announce Quarterly Sales of $770,000.00
Arbutus Biopharma Corp Expected to Announce Quarterly Sales of $770,000.00
$0.46 Earnings Per Share Expected for Tristate Capital Holdings Inc  This Quarter
$0.46 Earnings Per Share Expected for Tristate Capital Holdings Inc This Quarter
DexCom, Inc.  Expected to Post Quarterly Sales of $283.08 Million
DexCom, Inc. Expected to Post Quarterly Sales of $283.08 Million
E*TRADE Financial Corp  Expected to Announce Earnings of $1.03 Per Share
E*TRADE Financial Corp Expected to Announce Earnings of $1.03 Per Share


© 2006-2018 Ticker Report